Hoog, Meredith
Paczkowski, Rosirene
Huang, Ahong
Halpern, Rachel
Buysman, Erin
Stackland, Sydnie
Zhang, Yiran
Wangia-Dixon, Ruth
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 23 June 2023
Accepted: 1 September 2023
First Online: 23 September 2023
Declarations
:
: Meredith Hoog is an employee and stockholder of Eli Lilly and Company. Rosirene Paczkowski is an employee of GSK and was an employee of Eli Lilly and Company during this research. Ahong Huang is an employee of Tigermed-BDM. Rachel Halpern, Erin Buysman, and Yiran Zhang are employees of Optum, Inc. Ruth Wangia-Dixon is an employee of Elevance Health and was an employee of Optum, Inc. during this research. Sydnie Stackland was an employee of Optum, Inc. during this research.
: All study data were accessed with protocols compliant with the US patient confidentiality requirements, including the HIPAA of 1996. As this study used only de-identified data compliant with the HIPAA from the ORD, it was exempt from institutional review board approval. The study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments.